Curaleaf Celebrates President Trump’s Landmark Rescheduling of Cannabis Under Controlled Substances Act
Trump Administration's Rescheduling Opens New Avenues for Research, Medical Advancement, and Investment Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer cannabis products, today applauds the Trump Administration's action to implement the most impactful federal cannabis reform of the past fifty years by rescheduling cannabis as a […]